⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GANX News
Gain Therapeutics, Inc. Common Stock
Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference
globenewswire.com
GANX
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
globenewswire.com
GANX